Evaluating retinal blood flow in patients with high myopia
Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA .
This study is testing how blood flows in the retinas of people with high myopia who don’t have serious eye problems to better understand their condition.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 15 Years and up |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag, Sohag Governorate) |
| Trial ID | NCT06596408 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the macular vascular density in patients with high myopia who do not have pathological myopic maculopathy. It is a cross-sectional observational study involving approximately 50 patients attending the ophthalmology outpatient clinic at Sohag Teaching Hospital. The evaluation will be conducted using optical coherence tomography angiography (OCTA) to provide insights into retinal blood flow in this specific patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with axial high myopia of -6 spherical refractive error or more, without any other ocular or systemic diseases affecting ocular circulation.
Not a fit: Patients with a history of ocular diseases, previous intraocular surgeries, or those with pathological myopic maculopathy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of retinal health in high myopia, potentially leading to better management strategies for patients.
How similar studies have performed: While there may be studies on retinal vascular density in myopia, this specific approach using OCTA in high myopia without pathological conditions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria wil include : * All myopic patients with axial high myopia (-6 spherical refractive error or more) of different age groups . Exclusion Criteria will include : * -History of other any ocular diseases , systemic diseases that may affect the ocular circulation . * Previous intraocular surgery or ocular injury . * Any patient with pathological myopic maculopathy as epiretinal membrane, foveoschisis, macular holes, lamellar holes, Lacquers cracks, choroidal neovascularization and retinal atrophy .
Where this trial is running
Sohag, Sohag Governorate
- Sohag University — Sohag, Sohag Governorate, Egypt (Recruiting)
Study contacts
- Study coordinator: Sara Magdy Mohammed, Master degree
- Email: saramagdy@med.sohag.edu.eg
- Phone: 00201096507733
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.